- Home
- ALDX vs RGCO Comparison
ALDX vs RGCO Comparison
Compare ALDX & RGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- RGCO
- Stock Information
- Founded
- ALDX 2004
- RGCO 1912
- Country
- ALDX United States
- RGCO United States
- Employees
- ALDX N/A
- RGCO N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- RGCO Oil & Gas Production
- Sector
- ALDX Health Care
- RGCO Utilities
- Exchange
- ALDX Nasdaq
- RGCO Nasdaq
- Market Cap
- ALDX 270.7M
- RGCO 236.5M
- IPO Year
- ALDX 2014
- RGCO N/A
- Fundamental
- Price
- ALDX $4.81
- RGCO $19.68
- Analyst Decision
- ALDX Strong Buy
- RGCO
- Analyst Count
- ALDX 2
- RGCO 0
- Target Price
- ALDX $9.50
- RGCO N/A
- AVG Volume (30 Days)
- ALDX 1.2M
- RGCO 18.8K
- Earning Date
- ALDX 08-12-2025
- RGCO 08-12-2025
- Dividend Yield
- ALDX N/A
- RGCO 4.20%
- EPS Growth
- ALDX N/A
- RGCO N/A
- EPS
- ALDX N/A
- RGCO 1.29
- Revenue
- ALDX N/A
- RGCO $91,314,087.00
- Revenue This Year
- ALDX N/A
- RGCO $10.87
- Revenue Next Year
- ALDX $29.89
- RGCO $3.26
- P/E Ratio
- ALDX N/A
- RGCO $15.28
- Revenue Growth
- ALDX N/A
- RGCO 9.74
- 52 Week Low
- ALDX $1.14
- RGCO $19.05
- 52 Week High
- ALDX $7.20
- RGCO $24.20
- Technical
- Relative Strength Index (RSI)
- ALDX 53.97
- RGCO 31.98
- Support Level
- ALDX $5.21
- RGCO $20.18
- Resistance Level
- ALDX $5.35
- RGCO $23.22
- Average True Range (ATR)
- ALDX 0.33
- RGCO 0.71
- MACD
- ALDX -0.12
- RGCO -0.20
- Stochastic Oscillator
- ALDX 40.70
- RGCO 0.00
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About RGCO RGC Resources Inc.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.